Video wird geladen...
Video konnte nicht geladen werden
BREAKING NEWS: First-in-the-World Ivermectin, Mebendazole and Fenbendazole Protocol in Cancer has been peer-reviewed and published! (4 min 52 seconds) InfoWars did a media piece on this breakthrough in Cancer Treatment. These are Critical medicines to have on hand. They ship from outside the USSA by our Freedom Crew. They... show more
23,760 Aufrufe • vor 1 Tag •via X (Twitter)
0 Kommentare
Keine Kommentare verfügbar
Kommentare vom Original-Post werden hier angezeigt
![Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. Dr. Sulack Pete "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases." Follow me for more Bombshell. #Fenbendazole #Ivermectin #Cancercure](https://image.24vids.com/tw-2076674479695024226/amplify_video_thumb/2076674231136333824/img/S83Z7cJ1QdkerVCs.jpg)
![Ivermectin & Fenbendazole Cancer Secrets Revealed w/ Dr. William Makis Remarkable success stories are pouring in from people using Ivermectin and Fenbendazole to combat cancer. Mel Gibson dropped a bombshell on Joe Rogan’s podcast, revealing that three of his friends had “stage four cancer,” and now “all three of them don’t have cancer right now at all.” “And they had some serious stuff going on,” Gibson emphasized. Dr. William Makis, who treated one of Gibson’s friends, has been rigorously researching the anti-cancer potential of Ivermectin and Fenbendazole over the past two years. During that time, he discovered, “There are over 100 papers on the success of Ivermectin and cancer.” “Ivermectin can actually kill cancer stem cells,” Dr. Makis explained, noting that it targets the cells “that chemo can’t kill.” He added, “It can also reverse resistance that cancer cells develop to certain types of chemotherapy.” The benefits extend further. “It [Ivermectin] makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitizer,” he shared. Yet, research into these applications has been neglected. “Big Pharma has completely abandoned it. Ivermectin is off-patent. No one’s going to make money on it,” Dr. Makis pointed out. Taking action where others haven’t, Dr. Makis applied his findings to his practice. “I have over 1,000 cancer patients who are on either a combination of Ivermectin and Fenbendazole or Ivermectin and Mebendazole,” he shared. Some of his patients were “given a terminal diagnosis” but are now “cancer-free” or have their “cancer under control.” “Patients, for example, who are taking combinations of chemo and Ivermectin or radiation and Ivermectin are seeing dramatic results that oncologists have never seen, that radiation oncologists have never seen,” Dr. Makis shared. “Tumors shrinking down to almost nothing, liver metastases disappearing, brain metastases disappearing.” “There are hundreds, if not thousands, of testimonials” documenting the success stories of Ivermectin and Fenbendazole, Dr. Makis added, offering hope to patients seeking alternatives. He strongly believes that “the future of cancer care is in repurposed drugs.” For more information on the use of Ivermectin and Fenbendazole for cancer, follow Dr. William Makis (MakisMD) on 𝕏. --> MakisMD (See 9 More Revealing Stories Below)](https://image.24vids.com/tw-1878578096535683583/amplify_video_thumb/1878564688390189056/img/j__0WWkczsp4qTg3.jpg)
![Oncologist Dr. William Makis describes getting attacked by the president of City of Hope cancer centers for publishing success stories using antiparasitics to treat turbo cancers: "These antiparasitics are being heavily attacked and are being suppressed every time I mention ivermectin, mebendazole, [and] fenbendazole. And I have hundreds of success stories...." This clip of Dr. Makis, a radiologist, oncologist, and cancer researcher, is taken from a panel discussion posted to the World Council for Health Rumble channel on November 24, 2025. ---------------Partial transcription of clip---------------- "So these antiparasitics are being heavily attacked, and are being suppressed every time I mention ivermectin, mebendazole, fenbendazole, and I have hundreds of success stories. I get attacked. I get attacked by mainstream doctors and mainstream oncologists. "And just going back to what Kevin McKernan said about this phenomenon of trying to retract papers, get good papers retracted, I've had this happen to me very recently. We published recently a paper on fenbendazole. Three cases of stage four cancer patients who had failed three or four or five lines of chemotherapy, and mainstream oncology regimens. These cancer patients were dying. They took fenbendazole and they became cancer free. And we followed them up, up to three years. They stayed cancer three for up to three years. So we had three cases. We published this paper a few months ago. This was only the second paper published on the antiparasitic fenbendazole in the past five years with human cases. The first one was published by Stanford University in 2021. And so they had published three cases in 2021. We published three cases in 2025. Within a month or two of the publication of our paper. Now it passed peer review and it was published. We were attacked by the editor of the paper, who's actually the president of the City of Hope cancer centers in the United States, in Atlanta, Chicago, and Phoenix. "This was Dr. Maurice [Maurie] Markman, President of City of Hope, so a big time oncologist, with a lot of, you know, big pharma funding behind him. He said he's going to pull the paper. And they didn't have a good reason to pull the paper. In fact, the reason that they were putting was that I was giving, you know, medical advice to other cancer patients with fenbendazole. And so that was some kind of a conflict of interest. And because, you know, that wasn't declared in the way they liked, that they were going to pull the paper. "And so, you know, this is an attack. We're going to see these attacks not just on Kevin McKernan and David Speicher's work in trying to make the link between Covid vaccines and these turbo cancers. But even those of us who are going to try to treat these patients, and help these patients and try to get that work published with antiparasitics and these turbo cancers, we're being attacked, and our papers are being attacked for retraction as well." #Fenbendazole #Ivermectin #Cancercure](https://image.24vids.com/tw-2072362082264047725/amplify_video_thumb/2072361878592933888/img/oHkZrV5xM-aB9mvY.jpg)
![Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." This clip of Dr. Makis (William Makis), a radiologist, oncologist, and cancer researcher, is taken from an interview with Seth Holehouse () posted to Rumble on November 21, 2025. ----------------Partial transcription of clip--------------- "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases."](https://image.24vids.com/tw-1992289499234353444/amplify_video_thumb/1992288090514427904/img/AnV6ey4me_UypXaN.jpg)
